Search Results 1251-1260 of 16264 for monoclonal antibody

  1. A Study of KRN23 in Adult Subjects with Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome - Mayo Clinic

    Have used a therapeutic monoclonal antibody, including KRN23, within 90 days prior to Screening or have a history of allergic or anaphylactic reactions to any ...

  2. Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C Melanoma Patients

    Previous in vivo exposure to monoclonal antibodies for biological therapy in the 6 weeks before enrollment. Planned administration of growth factors or ...

  3. Phase I Dose Escalation Study for BAY 1251152 in Patients With Advanced Cancer - Mayo Clinic

    Major surgery, significant trauma, wide-field radiotherapy, or therapy with monoclonal antibodies within 4 weeks before the first dose of study drug ...

  4. Tests and treatments - Mayo Clinic

    At Mayo Clinic, you have access to the latest advances and proven innovations for diagnosing and treating cancer. Not all services are provided at all ...

  5. Phase II Venetoclax, Obinutuzumab and Bendamustine in High Tumor Burden Follicular Lymphoma as Front Line Therapy - Mayo Clinic

    Patients must be tested for hepatitis B virus (HBV), hepatitis B surface antigen (HBsAg+) and hepatitis C (HCV) antibody within 6 weeks of registration.

  6. A Study of Immune-Mediated Activation of Astrocytes in Healthy Volunteers - Mayo Clinic

    The purpose of this study is to characterize the astrocyte response to various inflammatory drivers in the presence of innate immune cells collected from ...

  7. Safety and Efficacy of ALLO-715 and ALLO-647 BCMA Allogenic CAR T Cells in in Adults With Relapsed or Refractory Multiple Myeloma (UNIVERSAL) - Mayo Clinic

    ... antibody (ALLO-647)-containing regimen in 43 patients with relapsed/refractory multiple myeloma as part A of the ongoing first-in-human phase 1 UNIVERSAL trial.

  8. Center for Multiple Sclerosis and Autoimmune Neurology Research Procedures - Mayo Clinic

    About this study. The purpose of this study is to find and identify autoreactive lymphocytes including autoantibody producing B cells and autoreactive ...

  9. A Study to Evaluate the Combination of Binimetinib and Palbociclib in Treating Patients with KRAS and NRAS Mutant Metastatic or Unresectable Colorectal Cancer - Mayo Clinic

    Prior treatment ≤ 21 days prior to registration/randomization with any other chemotherapy, small molecule inhibitor (e.g., regorafenib), monoclonal antibody, ...

  10. Grant Archives — Immunity and Fibrosis Platform - Center for Biomedical Discovery - Mayo Clinic Research

    The investigators hypothesize that using a novel antibody, CD3 monovalent (mono) Fab, to stimulate T cells will provide oncologists with another way to boost ...